Roquefort Investments PLC (LSE:ROQ) was formed as an investment company to acquire businesses focused on early-stage opportunities in the medical biotechnology sector with the aim of generating optimal returns for both the target businesses and its shareholders.
Co-founder and chairman Steve West spoke to Proactive's Stephen Gunnion about the company's investments, strategy and the progress it has made since its IPO in March.